In recent months, Philip Morris International presented scientific evidence to the FDA’s Tobacco Products Scientific Advisory ...

Experts from Philip Morris International (PMI) (NYSE: PM) yesterday presented scientific evidence to the U.S. Food and Drug Administration’s (FDA) Tobacco Products Scientific Advisory Committee (TPSAC ...

PMI scientists presented data to the FDA’s Tobacco Products Scientific Advisory Committee (TPSAC) as part of the FDA’s ...

FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from ...

A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...